Stock APPB APPLIED BIOSCIENCES CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Applied Biosciences Corp. Share Price

Equities

APPB

US03815L1026

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 14:30:19 23/10/2023 BST 		5-day change 1st Jan Change
0.0002 USD -.--% Intraday chart for Applied Biosciences Corp. -.--% -.--%
2020 Applied BioSciences Corp. Terminates Agreement to Offer Test Kits CI
2020 Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19 CI

Financials

Sales 2018 0.2 15.76 Sales 2019 0.71 56.41 Capitalization 22.68M 1.81B
Net income 2018 -2M -160M Net income 2019 -2M -160M EV / Sales 2018 104,018,506 x
Net cash position 2018 60.93K 4.86M Net cash position 2019 22.04K 1.76M EV / Sales 2019 32,047,470 x
P/E ratio 2018
-12.7 x
P/E ratio 2019
-7.7 x
Employees 25
Yield 2018 *
-
Yield 2019
-
Free-Float 65.92%
More Fundamentals * Assessed data

Chart Applied Biosciences Corp.

Dynamic Chart

Latest news about Applied Biosciences Corp.

Applied BioSciences Corp. Terminates Agreement to Offer Test Kits CI
Applied BioSciences Begins Offering Coronavirus Test Kit to the General Public to Combat Spread of COVID-19 CI
Applied Biosciences Corp. Announces Resignation of Raymond Urbanski as Chief Executive Officer and Director CI
Applied Biosciences Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2019 CI
Applied Biosciences Corp. Reports Earnings Results for the Second Quarter Ended September 30, 2019 CI
Pond Naturals Signs Agreement with Applied BioSciences to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products CI
Applied Biosciences Corp. Appoints Michael Beaubaire as Director CI
Applied BioSciences Corp. Announces Resignation of John Brady as Director CI
Applied Biosciences Corp. announced that it has received $0.25 million in funding from FirstFire Capital Management LLC CI
Applied Biosciences Corp. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC CI
Applied Biosciences Corp. Reports Earnings Results for the First Quarter Ended June 30, 2019 CI
Applied Biosciences Corp. Reports Earnings Results for the Full Year Ended March 31, 2019 CI
Applied Biosciences Corp. Auditor Raises 'Going Concern' Doubt CI
Applied BioSciences Launches Champ Organics CBD Product Line CI
Applied Biosciences Corp. Appoints Raymond Urbanski as Chief Executive Officer and Director CI
More news

Press releases Applied Biosciences Corp.

Biocon Academy Conducts its 8th Graduation Day AQ
University of Sunderland in London : Study dips into world of Wild Sea Women AQ
Biocon Academy Conducted Graduation Ceremony for 185 Students across Four Programs AQ
Applied Biosciences : Pandemic For Profit? – SEC Enforcement Patrols Press Releases AQ
COVID-19: A Review Of Recent Securities Fraud Enforcement Actions AQ
More press releases

Highs and lows

1 year
0.00
Extreme 0.0002
0.10
3 years
0.00
Extreme 0
0.44
5 years
0.00
Extreme 0
1.95
10 years
0.00
Extreme 0
5.00
More quotes

Managers and Directors - Applied Biosciences Corp.

Managers TitleAgeSince
David Colodner CEO
 Chief Executive Officer - -
David Fiene AUD
 Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
David Colodner CEO
 Chief Executive Officer - -
More insiders

Company Profile

Applied BioSciences Corp. is a vertically integrated company that is focused on the development of science-driven cannabinoid therapeutics/biopharmaceuticals. The Company delivers cannabidiol (CBD) products as well as testing and analytics capabilities to its customers. It sells consumer products, including health and wellness creams, tinctures, edibles, confections, clothing, apparel, and other various branded products. Its various brands include Remedi, Remedi Plus, HerbalPet, Champ Organics and Equine Care. Its products are focused on the medical, bioceutical and pet health industries. The Company's subsidiaries include Applied Products LLC, Trace Analytics, Inc., and API Holdings, LLC, among others.
Sector
Biotechnology & Medical Research
More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
APPLIED BIOSCIENCES CORP. Stock Applied Biosciences Corp.
-.--% 4.28K
MODERNA, INC. Stock Moderna, Inc.
+26.28% 42.68B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.99% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+45.32% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.36% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.47% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.58% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.75% 11.95B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-2.02% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. APPB Stock